Orthofix Medical Inc.
OFIXHealthcareNASDAQMedical Devices · Last scanned Jun 3, 2026
Scan Results
Daily timeframeHeadquartered within the healthcare sector, Orthofix Medical Inc. focuses on Medical Devices services and products. Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. The $392.5M market capitalization puts OFIX squarely in small-cap range for its industry. It operates through two segments, Global Spine and Global Limb Reconstruction.
Market Cap
$392.5M
Beta
0.79
P/E (TTM)
—
P/E (Fwd)
13.68
EPS (TTM)
$-1.50
EPS (Fwd)
$0.71
ROE
-13.4%
ROA
-3.3%
Cash
$120.3M
Total Debt
$262.3M
Free CF
$22.0M
52W Change
-10.9%
Annual Financials
Cash vs Debt
The company holds $120.3M in cash, though total debt stands at $262.3M. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Free cash flow comes in at $22.0M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. Return on equity stands at -13.4%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Revenue has grown from $460.7M (2022) to $822.3M (2025), reflecting a 78% increase over the period.
As with any equity investment, OFIX carries market risk, sector-specific risk, and company-specific risk that investors should evaluate in the context of their own portfolios. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Orthofix Medical Inc.'s trajectory.